After D-mab: Next-Generation Osteoporosis Drugs Focus On Building Bone

Anti-resorptive denosumab is what Amgen is counting on for its future growth. But denosumab may be the last of the current generation of drugs which prevent bone breakdown: newer drugs in development help build bone.